Clinical Trials of COVID-19 Vaccines by Russia's Biocad, Generium to Start in June

MOSCOW (Sputnik) - Clinical trials of the first COVID-19 vaccines developed by the Russian pharmaceutical companies Biocad and Generium should start in June, Industry and Trade Minister Denis Ma